Whole-genome sequencing could lead to faster, more accurate resistance testing.
The US Food and Drug Administration (FDA) today released new draft guidance that spells out when it's appropriate to disclose retail information for recalled products.
A phase 2 study of an adjuvanted subunit vaccine against tuberculosis (TB) in young and middle-aged adults with the latent form of the disease found that it was 54% effective against progression to the active pulmonary form of the disease. An international team led by scientists from GlaxoSmithKline, the vaccine's developer, reported its findings today in the New England Journal of Medicine.
TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.
The Nigeria Centre for Disease Control (NCDC) said today it is helping UK officials respond to their two recent monkeypox cases, which involve travelers from Nigeria, a country that has now reported 262 suspected cases.
Newer and repurposed drugs produced better results and fewer deaths than older treatments did.
The Coalition for Epidemic Preparedness Innovations (CEPI) recently announced a collaboration with Germany-based IDT Biologika worth up to $36 million to develop and produce a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV).
The substitution of bedaquiline for second-line injectable antibiotics (SLIs) in a small group of patients with multidrug-resistant tuberculosis (MDR-TB) resulted in improved outcomes, South African researchers report in Clinical Infectious Diseases.
A study today in Pediatrics suggests that a dose of parenteral antibiotics prior to discharge from the emergency department (ED) is likely not necessary for most young children with urinary tract infections (UTIs).
The changes prioritize newer medications and oral regimens over injectable drugs.
